Demand for refund on dud drugs

Charities have petitioned a pharmaceutical firm to cut the cost of a drug that can treat bone marrow cancer, so it can be used by the NHS in England and Wales. Myeloma UK, MacMillan Cancer Support and Leukaemia CARE have asked the manufacturer, Janssen-Cilag to adopt a similar stance on Revlimid to that taken with Velcade, for which refunds are given if it is ineffective on patients. The charities are also asking for the price of the drug to be reduced with a discount. Revlimid, which costs around £4,500 a month per patient, can extend the lives of myeloma patients for up to three years...